Carlsmed

United States - Carlsbad, California

• 19/03/2024
• Series C
• $52,500,000

Carlsmed’s mission is to improve outcomes and decrease the cost of healthcare for spine surgery . The company’s aprevo® devices are designed to improve the standard of care for surgical treatment of patients with adult spinal malalignment. Carlsmed uses patient data and proprietary digital technologies to create optimal surgical plans and personalized aprevo® spine fusion devices for each patient. The Carlsmed® aprevo® devices are FDA cleared and have been granted FDA Breakthrough Designation, an industry first for any implanted device, and are commercially available in the U.S.

Related People

Mike CordonnierFounder

United States - Carlsbad, California

Mike is a seasoned MedTech operator, entrepreneur, and cofounder of Carlsmed. Mike was named as an EY Entrepreneur of the Year and to the SD500 as one of the most influential people in San Diego. Mike has excelled in prior operating roles at private and public companies, including NuVasive Specialized Orthopedics, Zimmer Biomet, Orchid Orthopedics, X-Spine Systems, and YSI. Mike remains active in the entrepreneur community and serves as an advisor to San Diego based non-profits EvoNexus and SD Connect.

LinkedIn https://www.linkedin.com/in/mikecordonnier/